AAAAAA
Results: 1-25/39
Authors:
Bodurka-Bevers, D
Gershenson, DM
Citation: D. Bodurka-bevers et Dm. Gershenson, Gynecologic malignancies in older women - The Mirhashemi/Nieves-Neira/Averette article reviewed, ONCOLOGY-NY, 15(5), 2001, pp. 593
Authors:
Basen-Engquist, K
Bodurka-Bevers, D
Fitzgerad, MA
Webster, K
Cella, D
Hu, SH
Gershenson, DM
Citation: K. Basen-engquist et al., Reliability and validity of the functional assessment of cancer therapy-ovarian, J CL ONCOL, 19(6), 2001, pp. 1809-1817
Authors:
Hortobagyi, GN
Ueno, NT
Xia, WY
Zhang, S
Wolf, JK
Putnam, JB
Weiden, PL
Willey, JS
Carey, M
Branham, DL
Payne, JY
Tucker, SD
Bartholomeusz, C
Kilbourn, RG
De Jager, RL
Sneige, N
Katz, RL
Anklesaria, P
Ibrahim, NK
Murray, JL
Theriault, RL
Valero, V
Gershenson, DM
Bevers, MW
Huang, L
Lopez-Berestein, G
Hung, MC
Citation: Gn. Hortobagyi et al., Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A phase I clinical trial, J CL ONCOL, 19(14), 2001, pp. 3422-3433
Authors:
Miller, BE
Barren, BA
Dockter, ME
Delmore, JE
Silva, EG
Gershenson, DM
Citation: Be. Miller et al., Parameters of differentiation and proliferation in adult granulosa cell tumors of the ovary, CANCER DET, 25(1), 2001, pp. 48-54
Authors:
Castilleja, A
Ward, NE
O'Brian, CA
Swearingen, B
Swan, E
Gillogly, MA
Murray, JL
Kudelka, AP
Gershenson, DM
Ioannides, CG
Citation: A. Castilleja et al., Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity, MOL C BIOCH, 217(1-2), 2001, pp. 21-33
Authors:
Che, MX
Tornos, C
Deavers, MT
Malpica, A
Gershenson, DM
Silva, EG
Citation: Mx. Che et al., Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells, INT J GYN P, 20(4), 2001, pp. 323-328
Authors:
Levenback, C
Coleman, RL
Burke, TW
Bodurka-Bevers, D
Wolf, JK
Gershenson, DM
Citation: C. Levenback et al., Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer, GYNECOL ONC, 83(2), 2001, pp. 276-281
Authors:
Ramirez, PT
Ramondetta, LM
Burke, TW
Gershenson, DM
Brewer, MA
Citation: Pt. Ramirez et al., Metastatic uterine papillary serous carcinoma to the pericardium, GYNECOL ONC, 83(1), 2001, pp. 135-137
Authors:
Donato, ML
Gershenson, DM
Wharton, JT
Ippoliti, CM
Aleman, AS
Bodurka-Bevers, D
Bevers, MW
Burke, TW
Levenback, CF
Wolf, JK
Freedman, RS
Bast, RC
Gajewski, JL
Champlin, RE
Citation: Ml. Donato et al., High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer, GYNECOL ONC, 82(3), 2001, pp. 420-426
Authors:
Robinson, JB
Singh, D
Bodurka-Bevers, DC
Wharton, JT
Gershenson, DM
Wolf, JK
Citation: Jb. Robinson et al., Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies, GYNECOL ONC, 82(3), 2001, pp. 550-558
Authors:
Ramirez, PT
Levenback, C
Burke, TW
Eifel, P
Wolf, JK
Gershenson, DM
Citation: Pt. Ramirez et al., Sigmoid perforation following radiation therapy in patients with cervical cancer, GYNECOL ONC, 82(1), 2001, pp. 150-155
Authors:
Ramondetta, L
Burke, TW
Levenback, C
Bevers, M
Bodurka-Bevers, D
Gershenson, DM
Citation: L. Ramondetta et al., Treatment of uterine papillary serous carcinoma with paclitaxel, GYNECOL ONC, 82(1), 2001, pp. 156-161
Authors:
Munkarah, A
Levenback, C
Wolf, JK
Bodurka-Bevers, D
Tortolero-Luna, G
Morris, RT
Gershenson, DM
Citation: A. Munkarah et al., Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer, GYNECOL ONC, 81(2), 2001, pp. 237-241
Authors:
Fine, BA
Munoz, AK
Litz, CE
Gershenson, DM
Citation: Ba. Fine et al., Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist, GYNECOL ONC, 81(1), 2001, pp. 120-122
Authors:
Ortiz, BH
Ailawadi, M
Colitti, C
Muto, MG
Deavers, M
Silva, EG
Berkowitz, RS
Mok, SC
Gershenson, DM
Citation: Bh. Ortiz et al., Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors, CANCER RES, 61(19), 2001, pp. 7264-7267
Authors:
Bodurka-Bevers, D
Sun, CC
Gershenson, DM
Citation: D. Bodurka-bevers et al., Pharmacoeconomic considerations in treating ovarian cancer, PHARMACOECO, 17(2), 2000, pp. 133-150
Authors:
Lee, TV
Kim, DK
Peoples, GE
Castilleja, A
Murray, JL
Gershenson, DM
Ioannides, CG
Citation: Tv. Lee et al., Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptides, J INTERF CY, 20(4), 2000, pp. 391-401
Authors:
Anderson, BW
Peoples, GE
Murray, JL
Gillogly, MA
Gershenson, DM
Ioannides, CG
Citation: Bw. Anderson et al., Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals, CLIN CANC R, 6(11), 2000, pp. 4192-4200
Authors:
Lee, TV
Anderson, BW
Peoples, GE
Castilleja, A
Murray, JL
Gershenson, DM
Ioannides, CG
Citation: Tv. Lee et al., Identification of activated tumor antigen-reactive CD8(+) cells in healthyindividuals, ONCOL REP, 7(3), 2000, pp. 455-466
Authors:
Anderson, RW
Kudelka, AP
Honda, T
Pollack, MS
Gershenson, DM
Gillogly, MA
Murray, JL
Ioannides, CG
Citation: Rw. Anderson et al., Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides, CANCER IMMU, 49(9), 2000, pp. 459-468
Authors:
Vang, R
Medeiros, LJ
Silva, EG
Gershenson, DM
Deavers, M
Citation: R. Vang et al., Non-Hodgkin's lymphoma involving the vagina - A clinicopathologic analysisof 14 patients, AM J SURG P, 24(5), 2000, pp. 719-725
Authors:
Gordinier, ME
Ramondetta, LM
Parker, LP
Wolf, JK
Follen, M
Gershenson, DM
Bodurka-Bevers, D
Citation: Me. Gordinier et al., Survey of female gynecologic oncologists and fellows: Balancing professional and personal life, GYNECOL ONC, 79(2), 2000, pp. 309-314
Authors:
Bodurka-Bevers, D
Basen-Engquist, K
Carmack, CL
Fitzgerald, MA
Wolf, JK
de Moor, C
Gershenson, DM
Citation: D. Bodurka-bevers et al., Depression, anxiety, and quality of life in patients with epithelial ovarian cancer, GYNECOL ONC, 78(3), 2000, pp. 302-308
Authors:
Parker, LP
Parker, JR
Bodurka-Bevers, D
Deavers, M
Bevers, MW
Shen-Gunther, J
Gershenson, DM
Citation: Lp. Parker et al., Paget's disease of the vulva: Pathology, pattern of involvement, and prognosis, GYNECOL ONC, 77(1), 2000, pp. 183-189
Authors:
Morris, RT
Gershenson, DM
Silva, EG
Follen, M
Morris, M
Wharton, JT
Citation: Rt. Morris et al., Outcome and reproductive function after conservative surgery for borderline ovarian tumors, OBSTET GYN, 95(4), 2000, pp. 541-547